104 related articles for article (PubMed ID: 14578110)
1. Synthesis, characterization and in vitro evaluation of dimethyl-beta-cyclodextrin-4-biphenylylacetic acid conjugate.
Ventura CA; Paolino D; Pedotti S; Pistarà V; Corsaro A; Puglisi G
J Drug Target; 2003 May; 11(4):233-40. PubMed ID: 14578110
[TBL] [Abstract][Full Text] [Related]
2. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
Ventura CA; Giannone I; Paolino D; Pistarà V; Corsaro A; Puglisi G
Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
[TBL] [Abstract][Full Text] [Related]
3. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
[TBL] [Abstract][Full Text] [Related]
4. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
Minami K; Hirayama F; Uekama K
J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
[TBL] [Abstract][Full Text] [Related]
5. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
6. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery].
Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y
Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346
[TBL] [Abstract][Full Text] [Related]
7. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
8. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
Arima H; Kondo T; Irie T; Uekama K
J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
[TBL] [Abstract][Full Text] [Related]
9. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
Arima H; Adachi H; Irie T; Uekama K; Pitha J
Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
13. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
14. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
15. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
[TBL] [Abstract][Full Text] [Related]
16. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
17. Flutamide-hydroxypropy-beta-chiyclodextrin complex: formulation, physical characterization, and absorption studies using the Caco-2 in vitro model.
Zuo Z; Kwon G; Stevenson B; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2000; 3(2):220-7. PubMed ID: 10994035
[TBL] [Abstract][Full Text] [Related]
18. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
19. Effect of dimethyl-beta-cyclodextrin on nitrazepam stability.
Saleh SI; Rahman AA; Aboutaleb AE; Nakai Y; Ahmed MO
J Pharm Belg; 1993; 48(5):383-8. PubMed ID: 8120792
[TBL] [Abstract][Full Text] [Related]
20. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
